INDEX 847
St Bernard, 742
flea bite hypersensitivity, 241
nasal arteritis, 67,139,699, 706
uveodermatologic syndrome, 692
Salazopyrinseesulfasalazine
saluki, 434, 742
samoyed, 742
alopecia X, 338
sebaceous adenitis, 434, 648
uveodermatologic syndrome, 692
sample collection
bacterial culture, 30–31,34–35
cytology, 43–47
dermatophytes, 28–29,31–32
ear canal, 31, 45, 53
see alsobiopsy
sandflies, 458
Sarcoptes scabieivar.canis(sarcoptic mange,
scabies), 634, 639
clinical features, 635,642–643
diagnostics, 636
differential diagnosis, 177
therapeutics, 637–638
zoonotic potential,647, 729
sarcoptid mites, 634–638
clinical features, 64, 635,642–646
diagnostics, 636, 646
differential diagnosis, 636
skin scrapings, 43, 49
therapeutics, 637–638
sarolaner, 302, 638, 808
satellitosis, 40
scabicides, 637–638
scabiessee Sarcoptes scabieivar.canis
scaling, 12, 14
keratinization disorders, 430, 431, 440
scar, 14, 27
schipperke, 742
schnauzer comedo syndrome, 62, 434, 452
scleroderma, localized, 59, 73
sclerosis, 40
Scottish deerhound, 417
Scottish terrier, 742
allergic contact dermatitis, 266
atopic disease, 175
cutaneous adverse drug reactions, 273
skin and adnexal tumors, 673, 674
superficial necrolytic dermatosis, 617,
666
vasculitis, 698
Sealyham terrier, 175, 742
sebaceous adenitis (granulomatous), 648–651,
652–657
diffuse alopecia, 60, 82
exfoliative dermatosis, 62,97–98
keratinization defects, 434,449–451
patchy alopecia, 59, 74
therapeutics, 650–651
sebaceous adenocarcinoma
clinical features, 676, 688
histopathology, 678
prognosis, 680
signalment/history, 674
sebaceous adenoma
clinical features, 676,686–687
differential diagnosis, 677
histopathology, 678
predisposed breeds, 673
sebaceous epithelioma, 674, 678
sebaceous gland hyperplasia
clinical features, 676, 686
histopathology, 678
signalment/history, 433, 673
sebaceous gland tumors, 673
clinical features, 676,686–688
diagnostics, 677, 678
prognosis, 680
signalment/history, 673–674, 675
therapeutics, 678–679
seborrhea, 430
primary (idiopathic), 433, 435, 438,443–444
terminology, 431
see alsokeratinization disorders
seborrheic dermatitis, 338, 433, 481
selamectin, 550, 637, 809
selective serotonin reuptake inhibitors (SSRIs), 234
selegiline (L-deprenyl), 402, 403, 809
self-injurious dermatoses, 227–234
adverse food reactions, 287,292–294
atopic disease, 176,183, 185–186
clinical features, 228–230,235–238
comments, 234
diagnostics, 231–232
differential diagnosis, 230–231
etiology/pathophysiology, 227–228
flea bite hypersensitivity, 241, 250
lesion types, 13, 24
signalment/history, 228
therapeutics, 233–234
sensory dermatoses, cutaneous, 227
Sentinel tabletsseelufenuron + milbemycin oxime
Septraseetrimethoprim + sulfamethoxazole
serologic allergy tests, 178
serotonin syndrome, 234
Sertoli cell tumor, 61,88, 345–347
sertraline, 234
sex hormone-related dermatoses, 337, 339, 341,
345–350
S ́ezary cells, 368
S ́ezary syndrome (SS), 366, 367
shampoos
for adverse food reactions, 290
for atopic disease, 179
for atypical endocrinopathies, 341
for keratinization disorders, 437–438
for pyoderma, 142, 151, 217, 219